Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palonosetron Hydrochloride Capsules (Ruoshan ®) Used to Prevent and Control Chemotherapy for Tumor Patients Real World Study on the Safety of Nausea and Vomiting Reduction

NCT05690802 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05690802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05690802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palonosetron Hydrochloride Capsules (Ruoshan ®) Used to Prevent and Control Chemotherapy for Tumor Patients Real World Study on the Safety of Nausea and Vomiting Reduction
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 16, 2022
Completion date
May 30, 2029
Enrollment
1,060 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea and vomiting